Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Change in Account Payables: 2009-2024

Historic Change in Account Payables for Anika Therapeutics (ANIK) over the last 16 years, with Dec 2024 value amounting to -$2.5 million.

  • Anika Therapeutics' Change in Account Payables rose 107.87% to $231,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$956,000, marking a year-over-year increase of 11.23%. This contributed to the annual value of -$2.5 million for FY2024, which is 22681.82% down from last year.
  • As of FY2024, Anika Therapeutics' Change in Account Payables stood at -$2.5 million, which was down 22,681.82% from -$11,000 recorded in FY2023.
  • In the past 5 years, Anika Therapeutics' Change in Account Payables ranged from a high of $2.0 million in FY2022 and a low of -$2.5 million during FY2024.
  • Its 3-year average for Change in Account Payables is -$184,000, with a median of -$11,000 in 2023.
  • Per our database at Business Quant, Anika Therapeutics' Change in Account Payables surged by 278.64% in 2022 and then tumbled by 22,681.82% in 2024.
  • Over the past 5 years, Anika Therapeutics' Change in Account Payables (MRY) stood at $822,000 in 2020, then crashed by 233.82% to -$1.1 million in 2021, then surged by 278.64% to $2.0 million in 2022, then tumbled by 100.56% to -$11,000 in 2023, then plummeted by 22,681.82% to -$2.5 million in 2024.
  • Its Change in Account Payables stands at -$2.5 million for FY2024, versus -$11,000 for FY2023 and $2.0 million for FY2022.